Transplant hepatologist @UCSF studying cancer and autoimmune liver disease | @UCSFTransplant @BrighamGI @HarvardChanSPH @IcahnMountSinai @BrownUniversity alum
Joined November 2020
- Tweets63
- Following118
- Followers209
- Likes124
For anyone attending #NCCN2025 in Orlando, I'm excited to be speaking during the immune checkpoint inhibitor toxicities session tomorrow (Friday 3/28). Looking forward to talking about immune-mediated hepatitis with an oncology audience!
@NCCN @UCSFCancer #livertwitter
Michael Li, MD, MPH retweeted
🆕EASL Clinical Practice Guidelines on the management of #hepatocellularcarcinoma❗️
✅Updated advice for managing patients with #HCC & comprehensive review of pertinent data
Full text👉bit.ly/3VKZmcy
#CPGs
#LiverTwitter
@EASLnews
@EASLedu
@AleksanderKrag
Michael Li, MD, MPH retweeted
Apply for the #ACGInstitute Clinical Research Leadership Program!
Learn research leadership skills to maintain a successful independent research program. For US physician members 2-15 years post-fellowship.
Apply by November 15
➡️ gi.org/crlp
#CRLP @NeenaSAbrahamMD
Michael Li, MD, MPH retweeted
Immunotherapy for hepatocellular carcinoma
➡️The next evolution in expanding access to liver transplantation
Full text here👉journal-of-hepatology.eu/art…
@MichaelLiMD
@SherrieBhoori
#LiverTwitter
Michael Li, MD, MPH retweeted
@MichaelLiMD et al found that outcomes of high-grade immune checkpoint inhibitor hepatitis were similar in hospitalized and non-hospitalized patients, suggesting that not all patients with high ALT levels need to be hospitalized ow.ly/3qLG50SyXlI
Check out our review of immunotherapy in HCC with a focus on its role in expanding access to curative liver transplantation, now out in @JHepatology. It was amazing working with Vincenzo Mazzaferro and Neil Mehta in this joint San Francisco-Milan effort!
journal-of-hepatology.eu/art…
Michael Li, MD, MPH retweeted
Patients want to be in clinical trials but are rarely asked
And - key point - if your trial seeks to help them FEEL better, they really want to be asked
This study in @HepCommJournal from @MichaelLiMD is about PSC but the message is universal
journals.lww.com/hepcomm/ful…
Congrats @MelindaBWangMD! So happy that you’re staying, looking forward to working with you as a fellow!
We are so excited to announce our incoming all-star ✨cohort of GI Fellows starting in 2024! We are so lucky to have them 🥰 & cannot wait to work with them! @priyakathpalia @SaraLewinMD
Michael Li, MD, MPH retweeted
Incredibly honoured to attend #TLM23 as an Emerging Liver Scholar! Thank you so much @ggarciatsao and @AASLDFoundation for the opportunity and for those who welcomed me to the community!
🌟struck and inspired to help improve liver related care! @AASLDtweets #LiverTwitter
Michael Li, MD, MPH retweeted
Research by @MelindaBWangMD emphasizes the complexity of symptoms PSC patients experience & highlights the importance of considering these symptoms in clinical trials and future research. Learn more about why this research received a 2023 Abstract Award at aasldfoundation.org
Hey #livertwitter, if you'd like some validation for our amazing specialty, check out our study in @JNCCN showing the benefits of early GI/liver consultation in immune checkpoint inhibitor hepatitis: jnccn.org/view/journals/jncc…
@AlexSVogel @JordanSackMD @UCSFTransplant @BrighamGI
Michael Li, MD, MPH retweeted
Super excited to share our work developing the TeLeFI (Tele-Liver Frailty Index) to measure frailty in patients with cirrhosis via telemedicine!
authors.elsevier.com/c/1h0tA…
Michael Li, MD, MPH retweeted
From the newest members of our amazing group to the leaders at the top, my work family inspires greatness.
@JessBRubin @JoeCullaro @egnij @MonikaSarkarMD @MichaelLiMD @UCSFLiverCenter @UCSFTransplant
Michael Li, MD, MPH retweeted
This #WomensHistoryMonth, we're honored to highlight @MonikaSarkarMD, NIH-funded researcher in women's reproductive health and NAFLD and Chair, AASLD Women's Initiatives Committee. #LiverTwitter #WHM
@norahterrault
Huge congrats to UCSF IM resident and (hopefully) future hepatologist @MelindaBWangMD for receiving an @AmCollegeGastro Medical Resident Research Award to study the effects of Stelara in PSC. So excited to work with you on this study and many more!
#livertwitter @UCSFIMChiefs
I'm so honored to receive an @AmCollegeGastro Junior Faculty Development Award to study outcomes of HCC immunotherapy! Many thanks to my amazing co-mentors Jen Lai and Larry Fong and my @UCSFTransplant and @UCSFCancer collaborators for their support.
#ACGInstitute #livertwitter
Congratulations, Michael Li, MD, MPH, on your ACG Junior Faculty Development Award!
#ACGInstitute #FutureofGI #GITwitter
➡️ gi.org/research-grant-recipi…
Michael Li, MD, MPH retweeted
Congratulations to Dr. Walter Chan (@WalterChanMD), our Director of the Center for GI Motility & Director of Clinical Research Education, for his #promotion to Associate Professor of Medicine at Harvard Medical School @harvardmed 🍾
#BWHMotility #BrighamGIFaculty #BrighamGIAlum
Done with training! Finished transplant hepatology fellowship with my amazing co-fellows @RebeccaGKim and @egnij, and finally on to my first grown-up job.
Ran into the incoming @UCSFGIfellows on my way out, it felt like the circle of life!